OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?

OptimizeRx (OPRX) shares surged in the last session on above-average trading volume. However, the recent trend in earnings estimate revisions is unlikely to translate into further near-term price gains, suggesting caution until confirmatory fundamental or volume signals emerge.

Analysis

OptimizeRx (OPRX) shares surged in the last session on above-average trading volume. However, the recent trend in earnings estimate revisions is unlikely to translate into further near-term price gains, suggesting caution until confirmatory fundamental or volume signals emerge.